To differentiate between these two hypotheses, we attempted to test the PICOT-CCND2 correlation in normal tissues which are adjacent to the tumor (normal adjacent tissue; NAT), and compare them with the results obtained in the tumors. The gene discussed is GLRX3; the disease is neoplasm.